Form 4 holding
Director
Silexion Therapeutics Corp
- Security class
- Ordinary Shares
- Shares / value
- 25,399
- Estimated value
- $61,973
- Report date
- 20 Feb 2026
- Price
- $2.44
- Ownership
- By Guangzhou Sino-Israel Biotech Fund
Avner Lushi - Director at Silexion Therapeutics Corp
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- SLXN, SLXNW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Avner Lushi since 19 Sep 2025
Reported holdings for Avner Lushi in Silexion Therapeutics Corp
Form 4 holding
Director
Silexion Therapeutics Corp
- Security class
- Stock Option (right to buy ordinary shares)
- Shares / value
- 10,685
- Estimated value
- $26,071
- Report date
- 20 Feb 2026
- Price
- $2.44
- Ownership
- By Guangzhou Sino-Israel Biotech Fund
- Underlying class
- Ordinary Shares
- Underlying amount
- 10,685
Transaction history for Avner Lushi in Silexion Therapeutics Corp
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.